These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17211347)

  • 1. Primary hepatitis C virus infection in an intravenous drug user: kinetics of virological markers.
    Zachary P; Wendling MJ; Djeddi S; Schvoerer E; Ullmann M; Stoll-Keller F; Gut JP
    Gastroenterol Clin Biol; 2006 Dec; 30(12):1419-20. PubMed ID: 17211347
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-laboratory characteristics of acute viral hepatitis C in parenteral drug addicts].
    Kozhevnikova GM; Roslyĭ IM; Chuĭkova KI; Bobkova MR
    Ter Arkh; 1999; 71(11):10-4. PubMed ID: 10626325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection.
    Irving W;
    J Clin Virol; 2009 Feb; 44(2):vii, I. PubMed ID: 19309794
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters.
    Berg T; Hopf U; Stark K; Baumgarten R; Lobeck H; Schreier E
    J Hepatol; 1997 Mar; 26(3):484-91. PubMed ID: 9075653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review.
    Matheï C; Buntinx F; van Damme P
    J Viral Hepat; 2002 May; 9(3):157-73. PubMed ID: 12010503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum adenosine deaminase and hepatitis C virus infection].
    Fernández E; Riestra S; Rodríguez S; Rodríguez M
    Med Clin (Barc); 1995 Feb; 104(4):158. PubMed ID: 7898166
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical presentation of GB-C virus infection in drug abusers with chronic hepatitis C.
    Goeser T; Seipp S; Wahl R; Müller HM; Stremmel W; Theilmann L
    J Hepatol; 1997 Mar; 26(3):498-502. PubMed ID: 9075655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?
    Matheï C; Buntinx F; Van Damme P
    J Infect Dis; 2001 Sep; 184(5):659-60. PubMed ID: 11494175
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis G infection in drug abusers with chronic hepatitis C.
    Aikawa T; Sugai Y; Okamoto H
    N Engl J Med; 1996 Jan; 334(3):195-6. PubMed ID: 8531990
    [No Abstract]   [Full Text] [Related]  

  • 10. Two successive hepatitis C virus infections in an intravenous drug user.
    Proust B; Dubois F; Bacq Y; Le Pogam S; Rogez S; Levillain R; Goudeau A
    J Clin Microbiol; 2000 Aug; 38(8):3125-7. PubMed ID: 10921996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GB virus C (GBV-C)/hepatitis G virus (HGV) infection among intravenous drug users in Japan.
    Noguchi S; Sata M; Suzuki H; Ohba K; Mizokami M; Tanikawa K
    Virus Res; 1997 Jun; 49(2):155-62. PubMed ID: 9213390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
    Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
    World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hepatitis C virus reinfection after an intravenous drug injection].
    Payen JL; Izopet J; Barange K; Puel J; Selves J; Pascal JP
    Gastroenterol Clin Biol; 1998 Apr; 22(4):469-70. PubMed ID: 9762279
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users.
    Pirisi M; Toniutto P; Fabris C; Lombardelli T; Falleti E; Tisminetzky SG; Baralle F; Bartoli E
    J Clin Epidemiol; 1998 May; 51(5):423-7. PubMed ID: 9619970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional status of the interferon system in inapparent and clinical infection with hepatitis B and C viruses].
    Priĭmiagi LS; Kremerman IB; Tefanov VT; Tallo TG; Osadchaia GS
    Vopr Virusol; 1999; 44(2):85-8. PubMed ID: 10358905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal hepatitis C virus transmission--role of human immunodeficiency virus infection and injection drug use.
    Armstrong GL; Perz JF; Alter MJ
    J Infect Dis; 2003 Mar; 187(5):872; author reply 872-4. PubMed ID: 12599064
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users.
    Thomas DL; Shih JW; Alter HJ; Vlahov D; Cohn S; Hoover DR; Cheung L; Nelson KE
    J Infect Dis; 1996 Oct; 174(4):690-5. PubMed ID: 8843204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of HCV RIBA-2 indeterminate results in high-risk individuals: assessment by a new third-generation RIBA assay and PCR.
    García-Samaniego J; Soriano V; Silva E; Enríquez A; Muñoz F; González-Lahoz J; Di Bisceglie A
    Vox Sang; 1994; 66(2):148-9. PubMed ID: 7514325
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serologic reactivity and rate of alanine aminotransferase abnormalities.
    McOmish F; Chan SW; Dow BC; Gillon J; Frame WD; Crawford RJ; Yap PL; Follett EA; Simmonds P
    Transfusion; 1993 Jan; 33(1):7-13. PubMed ID: 7678709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.